167 related articles for article (PubMed ID: 9987712)
1. Specificity of omega-conotoxin MVIIC-binding and -blocking calcium channel antibodies in Lambert-Eaton myasthenic syndrome.
Nakao YK; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Mori M; Itoh M; Nagataki S
J Neurol; 1999 Jan; 246(1):38-44. PubMed ID: 9987712
[TBL] [Abstract][Full Text] [Related]
2. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Motomura M; Lang B; Johnston I; Palace J; Vincent A; Newsom-Davis J
J Neurol Sci; 1997 Mar; 147(1):35-42. PubMed ID: 9094058
[TBL] [Abstract][Full Text] [Related]
3. [Dosage and specificity of anti-calcium channel antibodies in Lambert-Eaton myasthenic syndrome].
Martin-Moutot N; de Haro L; Seagar M
Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S28-34. PubMed ID: 15269657
[TBL] [Abstract][Full Text] [Related]
4. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome.
Fukuda T; Motomura M; Nakao Y; Shiraishi H; Yoshimura T; Iwanaga K; Tsujihata M; Eguchi K
Ann Neurol; 2003 Jan; 53(1):21-8. PubMed ID: 12509844
[TBL] [Abstract][Full Text] [Related]
5. Passive transfer of Lambert-Eaton myasthenic syndrome induces dihydropyridine sensitivity of ICa in mouse motor nerve terminals.
Xu YF; Hewett SJ; Atchison WD
J Neurophysiol; 1998 Sep; 80(3):1056-69. PubMed ID: 9744921
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to synthetic peptides of the alpha1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome.
Takamori M; Iwasa K; Komai K
Neurology; 1997 May; 48(5):1261-5. PubMed ID: 9153453
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
Johnston I; Lang B; Leys K; Newsom-Davis J
Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
[TBL] [Abstract][Full Text] [Related]
8. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
[TBL] [Abstract][Full Text] [Related]
9. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.
Motomura M; Johnston I; Lang B; Vincent A; Newsom-Davis J
J Neurol Neurosurg Psychiatry; 1995 Jan; 58(1):85-7. PubMed ID: 7823075
[TBL] [Abstract][Full Text] [Related]
10. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
Waterman SA; Lang B; Newsom-Davis J
Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
[TBL] [Abstract][Full Text] [Related]
11. The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
Pinto A; Iwasa K; Newland C; Newsom-Davis J; Lang B
Muscle Nerve; 2002 May; 25(5):715-724. PubMed ID: 11994966
[TBL] [Abstract][Full Text] [Related]
12. Specificity of autoantibodies react with omega-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndrome.
Suenaga A; Shirabe S; Nakamura T; Motomura M; Tsujihata M; Matsuo H; Kataoka Y; Niwa M; Itoh M; Nagataki S
Muscle Nerve; 1996 Sep; 19(9):1166-8. PubMed ID: 8761275
[No Abstract] [Full Text] [Related]
13. GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
Shimizu F; Takeshita Y; Sano Y; Hamamoto Y; Shiraishi H; Sato T; Yoshimura S; Maeda T; Fujikawa S; Nishihara H; Kitanosono H; Tsujino A; Motomura M; Kanda T
Brain; 2019 Aug; 142(8):2253-2264. PubMed ID: 31236596
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel peptide can cause an autoimmune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
Komai K; Iwasa K; Takamori M
J Neurol Sci; 1999 Jul; 166(2):126-30. PubMed ID: 10475106
[TBL] [Abstract][Full Text] [Related]
15. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
16. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Leys K; Lang B; Johnston I; Newsom-Davis J
Ann Neurol; 1991 Mar; 29(3):307-14. PubMed ID: 1645944
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome.
Takamori M; Takahashi M; Yasukawa Y; Iwasa K; Nemoto Y; Suenaga A; Nagataki S; Nakamura T
J Neurol Sci; 1995 Nov; 133(1-2):95-101. PubMed ID: 8583238
[TBL] [Abstract][Full Text] [Related]
18. Phoneutria nigriventer omega-Phonetoxin IIA: a new tool for anti-calcium channel autoantibody assays in Lambert-Eaton myasthenic syndrome.
Martin-Moutot N; Haro Ld; Santos RG; Mori Y; Seagar M
Neurobiol Dis; 2006 Apr; 22(1):57-63. PubMed ID: 16289869
[TBL] [Abstract][Full Text] [Related]
19. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
20. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer.
Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E
Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
